Ursodeoxycholic acid and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Ursodeoxycholic acid (ursodiol), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Apixaban, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Fainting when taking Ursodeoxycholic acid. It is created by eHealthMe based on reports of 7,467 people who have side effects when taking Ursodeoxycholic acid from the FDA, and is updated regularly.

What is Ursodeoxycholic acid?

Ursodeoxycholic acid has active ingredients of ursodiol. It is often used in biliary cirrhosis primary. eHealthMe is studying from 7,528 Ursodeoxycholic acid users. Check the latest studies of Ursodeoxycholic acid.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,446 drugs and 3,548 conditions by eHealthMe. Check the latest studies of Fainting.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

7,467 people reported to have side effects when taking Ursodeoxycholic acid.
Among them, 40 people (0.54%) have Fainting.

Could Ursodeoxycholic acid cause Fainting?

Among these 40 people:

How long have people been on Ursodeoxycholic acid when they have Fainting? *

What is the gender of people who have Fainting when taking Ursodeoxycholic acid? *

female: 73.53 %
male: 26.47 %

What is the age of people who have Fainting when taking Ursodeoxycholic acid? *

What are other drugs people take besides Ursodeoxycholic acid? *

What are other side effects people have besides Fainting? *

Fall: 22 people, 55.00%
Wound: 20 people, 50.00%
Dizziness: 7 people, 17.50%
Cough: 5 people, 12.50%
Neuropathy Peripheral (surface nerve damage): 4 people, 10.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 7.50%
Broken Bone: 3 people, 7.50%
Thrombocytopenia (decrease of platelets in blood): 3 people, 7.50%
Disturbance In Attention: 3 people, 7.50%
Posterior Reversible Encephalopathy Syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss): 3 people, 7.50%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 12.50%
Liver Disorder (liver diseases): 3 people, 7.50%
Bone Pain: 3 people, 7.50%
Constipation: 3 people, 7.50%
Gastric Ulcer (stomach ulcer): 3 people, 7.50%
Systemic Mycosis (fungal infections of the body): 3 people, 7.50%
Bleeding Disorders: 3 people, 7.50%
Cardiac Failure Congestive: 2 people, 5.00%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 5.00%
Neuropathy Peripheral (surface nerve damage): 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodeoxycholic acid and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ursodeoxycholic acid:

Ursodeoxycholic acid (7,528 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Ursodeoxycholic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,446 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,548 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Ursodeoxycholic acid) and Ursodeoxycholic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.